Latest News

Prostate Tumor Androgen Receptor Abnormality Not Associated with Taxane Resistance

Prostate Tumor Androgen Receptor Abnormality Not Associated with Taxane Resistance

Androgen receptor V7 (AR-V7) status does not predict response to taxane chemotherapy in metastatic castration-resistant prostate cancer (mCRPC).

Bicalutamide Improves Survival in Advanced Nonmetastatic Hormone-Naïve Prostate Cancer

Bicalutamide Improves Survival in Advanced Nonmetastatic Hormone-Naïve Prostate Cancer

Adding bicalutamide improves overall survival among patients with advanced nonmetastatic hormone-naïve prostate cancer.

4Kscore Might Reduce Unnecessary Prostate Biopsies

4Kscore Might Reduce Unnecessary Prostate Biopsies

The 4Kscore could dramatically reduce the number of unnecessary prostate biopsies.

Elderly Patients with Primary CNS Lymphoma Benefit from High-Dose Methotrexate Therapy

Elderly Patients with Primary CNS Lymphoma Benefit from High-Dose Methotrexate Therapy

Elderly patients with primary central nervous system lymphoma (PCNSL) benefit from high dose-methotrexate (HD-MTX) based therapy.

Reduced Target Volume Significantly Reduces Late Toxicities in Extremity Sarcoma

Reduced Target Volume Significantly Reduces Late Toxicities in Extremity Sarcoma

Significant reduction of late toxicities in extremity soft tissue sarcoma (STS) treated with preoperative image-guided radiation therapy (IGRT).

No Change in Ovarian Cancer Survival with Aggressive Surgery

No Change in Ovarian Cancer Survival with Aggressive Surgery

Complex surgery is not an independent predictor of survival in patients with advanced epithelial ovarian cancer (EOC) or primary peritoneal cancer (PPC).

Alternating Sunitinib, Everolimus Not Effective for Advanced Renal Cell Carcinoma

Alternating Sunitinib, Everolimus Not Effective for Advanced Renal Cell Carcinoma

Alternating regimen of sunitinib and everolimus lacked clinical activity in the treatment of patients with advanced renal cell carcinoma.

In Urologic Cancers, Suicide Deemed Public Health Concern

In Urologic Cancers, Suicide Deemed Public Health Concern

Suicide is a public health concern for patients with genitourinary cancer, especially bladder cancer.

Ramucirumab Associated with Increased Risk of Hypertension

Ramucirumab Associated with Increased Risk of Hypertension

Administration of ramucirumab to patients with cancer is associated with an increased risk of hypertension.

Addition of Bevacizumab to Chemo for Small-Cell Lung Cancer Fails to Improve Outcomes

Addition of Bevacizumab to Chemo for Small-Cell Lung Cancer Fails to Improve Outcomes

Addition of bevacizumab to chemotherapy after induction did not improve outcome in previously untreated extensive small-cell lung cancer (SCLC).

Testicular Cancer May Raise Prostate Cancer Risk

Testicular Cancer May Raise Prostate Cancer Risk

Men who've had testicular cancer may be at increased risk for prostate cancer, although that risk is low.

Thyroid Ultrasound, Fine-Needle Aspiration May Increase Risk of Thyroid Cancer

Thyroid Ultrasound, Fine-Needle Aspiration May Increase Risk of Thyroid Cancer

An increased incidence of thyroid cancer may be the result of increased use of thyroid ultrasound and fine-needle aspiration (FNA).

CHEK2 Gene Mutations Predispose to Papillary Thyroid Cancer

CHEK2 Gene Mutations Predispose to Papillary Thyroid Cancer

Checkpoint kinase 2 (CHEK2) mutations predispose a person to thyroid cancer.

Farydak Approved for Treatment of Multiple Myeloma

Farydak Approved for Treatment of Multiple Myeloma

The FDA approved Farydak (panobinostat) in combination with bortezomib and dexamethasone for treatment of multiple myeloma.

Older Patients with Stage 1 Thyroid Cancer Paradoxically Show Better Survival

Older Patients with Stage 1 Thyroid Cancer Paradoxically Show Better Survival

Older patients with stage 1 differentiated thyroid cancer (DTC) paradoxically show better survival than expected based on age and sex.

More News

Health Care Expenditure Slowed in US

Health sector prices explain much of difference between U.S. and other high-spending countries.

EHR Use More Than Doubles

Almost 80% of doctors in the United States have switched from paper to electronic health records.

Many Docs Order Unnecessary Medical Tests

Most physicians believe that doctors order too many medical tests, yet half admit to doing so themselves in response to a patient who insists, a new survey shows.

Reducing Six Risk Factors May Prevent 37 Million Deaths

Several modifiable risk factors can cut chronic disease deaths over the next 15 years.

8 Million People Signed Up for Health Insurance

Eight million Americans signed up for private health insurance during the just-concluded first enrollment period under the Affordable Care Act.

Majority of Women Lack Accurate Knowledge of Their Own Breast Cancer Risk

Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.

Survey Identifies Modifiable Barriers to Mammography Screening Among Rural US Women

A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.

Perioperative MRI of Uncertain Benefit for Women with DCIS

The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.

Dr. Edith Perez's Recommended Abstracts at BCS 2013

ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.

Radiotherapy for DCIS Is Not Associated With Increased Cardiovascular Disease

Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs